Arphra/Issuer/UTHR

UTHR

United Therapeutics Corporation

HealthcareBiotechnologyUSUSD

$537.25

LiveJun 02, 2026

AI Brief

Market cap

$22.8B

52w range

272.12 – 609.35

P / E

—

EPS

—

Volume

294.5K

Revenue · FY

—

Explain this page

Arphra AIPlain-English read on United Therapeutics Corporation’s valuation

AI Issuer Brief

Arphra AI

Loading cached brief…

Insider · 30d

Bought

0 txns

Sold

$2.47M

10 txns

Net flow

−$2.47M

Full history →

Price

DB · prices_daily

1M 6M 1Y 5Y

No price history in prices_daily for UTHR.

Peers

No peer list available for UTHR.

Price change · trailing returns

Live

1D	5D	1M	3M	6M	YTD	1Y	3Y	5Y	10Y	Max
-1.35%	-5.96%	-5.81%	+4.56%	+13.31%	+10.26%	+65.06%	+147.33%	+212.97%	+343.90%	+8716.41%

Aftermarket

Live

Jun 02, 07:20 PM

Last trade

$537.25

1 sh

Bid

$537.02

51 sh

Ask

$537.48

80 sh

Spread

$0.460

Sector & industry today

Live

Sectors

Energy
+1.61%
Industrials
+1.32%
Basic Materials
+1.28%
Technology
+1.24%
Utilities
+0.95%
Consumer Cyclical
+0.50%
Consumer Defensive
+0.45%
Financial Services
+0.34%
Real Estate
+0.21%
Healthcare
-0.06%
Communication Services
-0.40%

Top industries (issuer's industry highlighted)

Biotechnology
-1.10%
Real Estate - Services
+5.06%
Electronic Gaming & Multimedia
-4.96%
Computer Hardware
-4.89%
Hardware, Equipment & Parts
+4.68%
Agricultural - Machinery
+3.29%
REIT - Office
+3.20%
Communication Equipment
+3.15%
Information Technology Services
+3.06%
Oil & Gas Energy
+2.97%
Auto - Parts
+2.90%
Apparel - Footwear & Accessories
-2.61%

Fair value

Football field →

Weighted blend

—

— vs spot

Recommendation

n/a

0 of 0 methods

Method spread

0bull0bear

±5% threshold

Analyst PT consensus: $636.83 (+18.54%)

Total assets

—

Total debt

—

Cash & equiv

—

Operating CF

—

Free cash flow

—

Buybacks

—

Analyst view

Consensus target

—

No price-target data returned for this ticker.

Recent actions

0 ↑0 ↓0 hold

No recent grade actions.

News

DB · news_items

Recent quarters

All financials →

Period	Revenue	Net income	EPS

Recent insiders

All →

Insider	Action	Shares	Value	Date
ROTHBLATT MARTINE A director, officer: Chairperson & CEO	Sell	56	$32.67K	May 12, 2026
ROTHBLATT MARTINE A director, officer: Chairperson & CEO	Sell	106	$60.6K	May 12, 2026
ROTHBLATT MARTINE A director, officer: Chairperson & CEO	Sell	240	$136.52K	May 12, 2026
ROTHBLATT MARTINE A director, officer: Chairperson & CEO	Sell	293	$167.92K	May 12, 2026
ROTHBLATT MARTINE A director, officer: Chairperson & CEO	Sell	400	$228.13K	May 12, 2026
ROTHBLATT MARTINE A director, officer: Chairperson & CEO	Sell	401	$230.05K	May 12, 2026

Income statement · annual

Open Financials →

Period	Revenue	Op income	Net income	EPS	Net margin